In 2018, Prestipino et al. described that oncogenic JAK2V617F mutations cause the up-regulation of PD-L1 in myeloproliferative neoplasms, thereby enabling these cells to escape from the immune system [192]. This evidence concerns the gene CD274 and myeloproliferative disorder.